UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2006

 

Commission File Number: 001-16829

 

 

 

Bayer Aktiengesellschaft

 

 

Bayer Corporation*

 

 

(Translation of registrant’s name into English)

 

 

 

Bayerwerk, Gebaeude W11

 

 

Kaiser-Wilhelm-Allee

 

 

51368 Leverkusen

 

 

Germany

 

 

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ý    Form 40-F o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes o    Noý

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

                          .

 

*   Bayer Corporation is also the name of a wholly-owned subsidiary of the registrant in the United States.

 

 



 

 

Exhibit List

 

Description

99.1

 

Press Release, dated March 24, 2006.

99.2

 

Ad-hoc Notification pursuant to Section 15 of the German Securities Trading Act.

99.3

 

Publication of the decision to make a takeover offer pursuant to Section 10 Para 1 of the German Securities Acquisition and Takeover Act.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

 

 

 

Bayer Aktiengesellschaft

 

 

 

 

 

 

(Registrant)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

By:

/s/ Dr. Roland Hartwig

 

 

 

 

 

 

Name:

Dr. Roland Hartwig

 

 

 

 

 

 

Title:

General Counsel

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

By:

/s/ Dr. Alexander Rosar

 

 

 

 

 

 

Name:

Dr. Alexander Rosar

 

 

 

 

 

 

Title:

Head of Investor Relations

 

 

Date: March 23, 2006

 

 

3